News Articles Tagged: Amylin Receptor Agonist

Cagrilintide's Mechanism: Targeting Amylin and Calcitonin Receptors

Delve into how Cagrilintide works by interacting with amylin and calcitonin receptors, offering new insights for metabolic disorder research.

Clinical Insights into Cagrilintide: A Peptide for Future Obesity Therapies

Examining the clinical efficacy and research potential of Cagrilintide, a dual GLP and amylin receptor agonist, for developing advanced obesity and metabolic health treatments.